News Headlines Article

Avastin linked to flesh-eating disease, prompting new label warnings
San Francisco Business Times

Genentech Inc.’s cancer-fighting Avastin has been linked to 52 cases of flesh-eating disease over 15 years, prompting updated warnings by health authorities. The cases of necrotizing fasciitis — including 17 reports of fatalities — appeared to occur at a higher rate in people with weakened immune systems, according to South San Francisco-based Genentech. The Food and Drug Administration in March issued a label warning on Avastin, the world’s best-selling cancer drug with sales of roughly $6 billion, and Health Canada issued a similar warning May 2.